iKang Healthcare (KANG) Reports Q1 EPS of $0.06/ADS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Heng Ren Responds to iKang Healthcare (KANG) Management After Being Block from Conference Call
September 18, 2017 3:03 PM EDTThe discord continues between iKang Healthcare (NASDAQ: KANG) management and shareholder Heng Ren Partners LLC, as the latter was blocked from asking questions at iKang's quarterly earnings conference call. According to the widely published letter, Heng Ren was prevented from participating on the call after registering to attend, absent any mention of an "invitation-only" event, that... More
